X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (77) 77
male (50) 50
female (48) 48
index medicus (46) 46
adult (41) 41
middle aged (32) 32
adolescent (28) 28
oncology (27) 27
hodgkin disease - drug therapy (21) 21
vaccines (21) 21
hematology (19) 19
immunology (19) 19
disease (18) 18
aged (17) 17
antineoplastic combined chemotherapy protocols - therapeutic use (17) 17
safety (17) 17
treatment outcome (17) 17
chemotherapy (16) 16
clinical trials (16) 16
child (15) 15
young adult (15) 15
follow-up studies (14) 14
hodgkin's disease (14) 14
hodgkin disease - pathology (13) 13
immunization (13) 13
infant (13) 13
meningitis (13) 13
prognosis (13) 13
retrospective studies (13) 13
hodgkin disease - mortality (12) 12
hodgkin disease - therapy (12) 12
infectious diseases (11) 11
meningococcal vaccines - immunology (11) 11
antibodies, bacterial - blood (10) 10
brentuximab vedotin (10) 10
child, preschool (10) 10
combined modality therapy (10) 10
disease-free survival (10) 10
hodgkin disease - radiotherapy (10) 10
meningococcal vaccines - administration & dosage (10) 10
africa (9) 9
age (9) 9
children (9) 9
immunogenicity (9) 9
tetanus (9) 9
vaccination (9) 9
vaccines, conjugate - immunology (9) 9
abridged index medicus (8) 8
abvd (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (8) 8
bleomycin - administration & dosage (8) 8
lymphoma (8) 8
lymphomas (8) 8
medicine, research & experimental (8) 8
meningitis, meningococcal - prevention & control (8) 8
neoplasm staging (8) 8
public health (8) 8
survival rate (8) 8
cancer (7) 7
conjugate vaccine (7) 7
dacarbazine - administration & dosage (7) 7
doxorubicin - administration & dosage (7) 7
epidemics (7) 7
hodgkin disease - blood (7) 7
hodgkin lymphoma (7) 7
italy (7) 7
medical research (7) 7
medicine, general & internal (7) 7
microbiology (7) 7
radiotherapy (7) 7
studies (7) 7
therapy (7) 7
time factors (7) 7
aged, 80 and over (6) 6
allergy and immunology (6) 6
antibodies (6) 6
care and treatment (6) 6
disease progression (6) 6
double-blind method (6) 6
hodgkin disease - metabolism (6) 6
immunohistochemistry (6) 6
mopp (6) 6
pertussis (6) 6
survival (6) 6
usage (6) 6
vinblastine - administration & dosage (6) 6
adolescents (5) 5
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
bleomycin (5) 5
bleomycin - therapeutic use (5) 5
confidence intervals (5) 5
dacarbazine - therapeutic use (5) 5
diphtheria (5) 5
doxorubicin - therapeutic use (5) 5
efficacy (5) 5
enzyme-linked immunosorbent assay (5) 5
epidemic meningitis (5) 5
gambia (5) 5
hematology, oncology and palliative medicine (5) 5
hematopoietic stem cell transplantation (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Expert Opinion on Biological Therapy, ISSN 1471-2598, 08/2018, Volume 18, Issue 8, pp. 841 - 849
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 07/2019, Volume 19, Issue 7, pp. 690 - 690
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2011, Volume 365, Issue 3, pp. 203 - 212
BEACOPP combination chemotherapy was compared with ABVD chemotherapy in advanced Hodgkin's disease. BEACOPP therapy was associated with higher initial rates of... 
CELL TRANSPLANT | MEDICINE, GENERAL & INTERNAL | VINORELBINE | MOPP | DISEASE | REGIMEN | IFOSFAMIDE | CHEMOTHERAPY | STANDARD | HYBRID | FERTILITY | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Etoposide - adverse effects | Prednisone - adverse effects | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Etoposide - therapeutic use | Combined Modality Therapy | Bleomycin - adverse effects | Remission Induction | Disease-Free Survival | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Vincristine - therapeutic use | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Procarbazine | Vinblastine | Disease | Etoposide | Prednisone | Family medical history | Radiation therapy | Patients | Lymphoma | Doxorubicin | Survival | Vincristine | Studies | Hepatitis | Dacarbazine | Cyclophosphamide | Chemotherapy | Bleomycin | Tomography | Lymphomas | Hodgkin's disease
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2018, Volume 36, Issue 20, pp. 2127 - 2128
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2011, Volume 364, Issue 24, pp. 2293 - 2304
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 01/2018, Volume 18, Issue 1, pp. 58 - 67
Journal Article